Helen Heslop, MD
Enriched profileProfessor, Departments of Medicine and Pediatrics (Section of Hematology-Oncology); Dan L Duncan Chair; Director, Center for Cell and Gene Therapy · Baylor College of Medicine
Helen Heslop is Professor, Departments of Medicine and Pediatrics (Section of Hematology-Oncology); Dan L Duncan Chair; Director, Center for Cell and Gene Therapy at Baylor College of Medicine. OpenAlex indexes 820 publications with 43,332 citations (h-index 102); ClinicalTrials.gov lists 23 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory. Clarivate lists Helen Heslop as a Highly Cited Researcher (Cross-Field, 2021-2022).
Data verified 14 Aug 2026
Overview
Updated 16 Oct 2026
Helen Heslop, MD, is Professor, Departments of Medicine and Pediatrics (Section of Hematology-Oncology) at Baylor College of Medicine. The public record shows 820 publications with 43,332 citations (h-index 102), centered on CAR-T cell therapy research, Cytomegalovirus and herpesvirus research, Virus-based gene therapy research. It also documents an investigator role on 23 registered clinical trials, industry payments reported by 8 companies, 9 NIH-funded awards (1997–2026).
- Top research focus: CAR-T cell therapy research
- 23 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 36 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 323.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
- Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)
Sponsor: The Methodist Hospital Research Institute
- 5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD)
Sponsor: Baylor College of Medicine
- Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
Sponsor: Tessa Therapeutics
Industry payments
Updated 16 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Autolus IncProgram year20251 payment
- PFIZER INC.Program year20251 payment
- National Marrow Donor ProgramProgram year20242 payments
NIH funding
Updated 16 Oct 2026
9 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:
Congress activity
Updated 16 Oct 2026
52 congress contributions (1998–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- CLL-1 chimeric antigen receptor T-cells for the treatment of Acute Myeloid Leukemia: A phase 1 clinical trial
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Journal of Clinical Oncology
2020
Most-cited works
by citation count (OpenAlex)Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/helen-heslop-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/baylor-college-of-medicine_congratulations-to-dr-helen-heslop-on-being-activity-6859168069772709888-Lsrn
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on recordEditorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
- Chair
BMT-CTN (Blood and Marrow Transplant Clinical Trials Network) Steering Committee, 2020-2022
2022 - Editorial Board
Molecular Therapy (Cell Press/ASGCT journal)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cell.com ↗ - Editorial Board
Molecular Therapy - Oncolytics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cell.com ↗ - Editorial Board
Transplantation and Cellular Therapy (ASTCT journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journals.elsevier.com ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Cross-Field20212022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tamest.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Center for Cell and Gene Therapy, joint program with Texas Children's Hospital and Houston Methodist Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Provider
Texas Children's Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texaschildrens.org ↗ - Leader
Cancer Cell & Gene Therapy Program, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
- Honorary Lecturer
Royal Free Hospital, London (past; fellowship in Department of Hematology, transplantation immunology research)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcm.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- Guest
"The Graft" podcast (stem cell transplant, cellular therapy, blood cancer topics)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - "Five Questions with Helen Heslop, M.D., for International Women's Day"
ASGCT interview feature
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asgct.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
Sankar Navaneethan, MD
Baylor College of Medicine
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center